Medicine shortage communication (MSC): Natpar (parathyroid hormone) (25, 50, 75 and 100 micrograms/dose powder and solvent for solution for injection)
Clinical investigation of medicinal products in the treatment of Myasthenia Gravis
Concept paper on the need of a guideline on clinical investigation of medicinal products in the treatment of Myasthenia Gravis
Review of the stepwise paediatric investigation plan (sPIP) pilot: Outcomes and future perspectives
Paediatric investigation plans
Human medicines European public assessment report (EPAR): Vantavo (previously Alendronate sodium and colecalciferol, MSD), alendronic acid,colecalciferol, Date of authorisation: 16/10/2009, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Palforzia, defatted powder of Arachis hypogaea L., semen (peanuts), Date of authorisation: 17/12/2020, Revision: 11, Status: Authorised
PSUSA/00002076/202506
PSUSA/00000812/202506
PSUSA/00002639/202507